LM-299
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LM-299, covering 2025-05-02 to 2025-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Study of LM-299 in Subjects Advanced Malignant Tumors [Phase 1, Phase 2]